ClinicalTrials.gov
public full text
Public Domain
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
This study will evaluate the safety, efficacy, tolerability, and systemic pharmacokinetics of 3 different doses of topical ophthalmic AGN-223575 suspension compared to AGN-223575 vehicle in patients with dry eye disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Confirmatory Study of OPC-12759 Ophthalmic Suspension#805397
- Dose-response Study of OPC-12759 Ophthalmic Suspension#842785
- A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease#911730
- Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease#863337
- A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients#991833
Record · ID 993242
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive